Good News: National Pharmaceutical Pricing Authority reduces price of stents

The National Pharmaceutical Pricing Authority (NPPA) Monday further slashed prices of the expensive cardiac stents while marginally increasing the cost of the basic stents.

After several rounds of consultation with various stakeholders, the NPPA cut the price of drug-eluting stent (DES) by Rs 1,710 (from Rs 29,600 to Rs 27,890) while increasing the price of bare metal stent (BMS) by Rs 400 (from Rs 7,260 to Rs 7,660).

The trade margin has been capped at 8%, the NPPA said in an order, which makes the current rates valid till March 31.

“All manufacturers of coronary stents, selling branded or non-branded… at prices higher than the ceiling price… shall revise the price of all such stents downward not exceeding the ceiling price,” the order said.

The order mandates hospitals to provide a clear break-up of the prices levied for other items used in medical procedures.

While there was fear of NPPA giving into industry pressure and increasing the price, experts feel the price could have been decreased further. “It is not really slashing of the price. There was scope for further reduction,” says GS Grewal, core committee member, Alliance of Doctors on Ethical Healthcare.


Photo: Dmitry Stolyarov, a heart surgeon, holds a stent.(REUTERS File Photo)

iMedWorks Ask Platform Links below:

1. Get a Medical Second Opinion
2. Search doctors and Request Appointment

You might also be interested in

What to do if you are choking and there’s no one around to help

Most people more or less understand what they have to do to if they see someone choking. But what's the ...
Read More

Difference between heart attack and cardiac arrest

People often think that a heart attack is the same thing as a cardiac arrest. This, however, is not true ...
Read More

Suicide prevention

Magnitude of the problem Suicide is among the top 20 leading causes of death globally for all ages. Every year, ...
Read More